Brief: SkinBioTherapeutics Says Sufficient Cash Runway To Support Ops Through Summer 2026
23/10/2024 15:30
Oct 23 (Reuters) - SkinBioTherapeutics PLC SBTX.L :
* SKINBIOTHERAPEUTICS - INTEGRATION UPDATE AND SHARE PRICE
MOVEMENT
* SKINBIOTHERAPEUTICS PLC - SUFFICIENT CASH RUNWAY TO
SUPPORT
OPERATIONS THROUGH SUMMER 2026
* SKINBIOTHERAPEUTICS PLC - PROJECTED ANNUALISED GROUP
TURNOVER
FOR FY25 OF £6.3M
Source text for Eikon: ID:nRSW3458Ja
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company